Celltrion signs $72.8 million deal for migraine drug Ajovy
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Celltrion secured a 100.4 billion won ($72.8 million) deal for contract development and manufacturing (CDMO) with TEVA Pharmaceuticals International for the migraine treatment Ajovy.
The contract runs through July 30 of next year, the pharmaceutical firm said Tuesday through an electronic disclosure.
Teva Pharmaceuticals is the U.S. subsidiary of the Israel-based Teva Pharmaceutical Industries.
The contract amount accounts to 4.6 percent of Celltrion’s 2023 revenue.
Celltrion is ramping up its efforts to enter the CDMO business, albeit as relative latecomer compared to Samsung Biologics and Lotte Biologics. The firm announced Friday that it planned to establish a fully owned CDMO subsidiary by the end of this year, with facility expansion and business operations set to begin next year.
Samsung Biologics operates four plants with a fifth plant under construction. The combined manufacturing capacity of the five plants is expected to be 784,000 liters (828,000 quarts) per year.
Lotte Biologics is building a plant with an annual production capacity of 360,000 liters.
The Korea Biotechnology Industry Organization projected that the global biopharmaceutical CDMO market would grow from $19.68 billion in 2023 to $43.85 billion in 2029, with an average annual growth rate of 14.3 percent.
BY LEE JAE-LIM [lee.jaelim@joongang.co.kr]
Copyright © 코리아중앙데일리. 무단전재 및 재배포 금지.
- Italian football icons visit Netflix’s 'Culinary Class Wars' winner’s pasta bar in Seoul
- Seoul city publishes list of 100 best restaurants, bars to visit ahead of Taste of Seoul week
- Rosé’s collab with Bruno Mars, ‘APT.,’ tops charts and takes over TikTok
- 'Culinary Class Wars' judge Anh Sung-jae told to 'lose weight' before filming hit show
- Candid photos of Jessi and producer Koala trigger controversy online
- Comedian Cho Sae-ho ties the knot on Sunday in star-studded ceremony
- Billions in Korean investment are at stake in the U.S. election
- Early 2000s come calling in Seoul as Yaya Toure, Park Ji-sung score in clash of the titans game
- Footballing legends face off, gladiator style, in Seoul
- Jessi leaves agency after alleged fan assault